XML 45 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
SEGMENT INFORMATION

(21) SEGMENT INFORMATION

The Company operates in one business segment, which primarily focuses on the development and commercialization of innovative biopharmaceuticals for serious diseases and medical conditions. All products are included in one segment because the majority of the Company’s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Net product revenues by product:

 

 

 

 

 

 

 

 

 

 

 

 

Vimizim

 

$

228,147

 

 

$

77,319

 

 

$

85

 

Naglazyme

 

 

303,090

 

 

 

334,447

 

 

 

271,244

 

Kuvan

 

 

239,336

 

 

 

202,987

 

 

 

167,422

 

Aldurazyme

 

 

97,912

 

 

 

105,616

 

 

 

83,545

 

Firdapse

 

 

16,037

 

 

 

18,047

 

 

 

16,064

 

Total net product revenues

 

$

884,522

 

 

$

738,416

 

 

$

538,360

 

 

The following table summarizes total revenues from external customers and collaborative partners by geographic region. Net product revenues are based on patient location for Vimizim, Naglazyme, Kuvan and Firdapse and Genzyme’s headquarters for Aldurazyme. Although Genzyme sells Aldurazyme worldwide, the royalties earned by the Company on Genzyme’s net sales are included in the U.S. region, as the transactions are with Genzyme whose headquarters are located in the U.S.

 

 

 

 

Years Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Total revenues by geographic region:

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

444,075

 

 

$

378,288

 

 

$

284,303

 

Europe

 

 

178,746

 

 

 

139,940

 

 

 

115,729

 

Latin America

 

 

142,305

 

 

 

118,562

 

 

 

67,339

 

Rest of world

 

 

124,769

 

 

 

112,494

 

 

 

81,114

 

Total revenues

 

$

889,895

 

 

$

749,284

 

 

$

548,485

 

 

The following table summarizes non-monetary long-lived assets by geographic region. Non-monetary long-lived assets primarily consists of property, plant and equipment, intangible assets, goodwill and deferred tax assets.

 

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Long-lived assets by geography:

 

 

 

 

 

 

 

 

United States

 

$

940,512

 

 

$

827,884

 

Europe

 

 

865,233

 

 

 

102,451

 

Rest of world

 

 

2,253

 

 

 

1,630

 

Total long-lived assets

 

$

1,807,998

 

 

$

931,965